Pharma-Bio Serv, Inc.
PBSV
$0.60
-$0.09-13.03%
OTC PK
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.18M | 9.64M | 9.60M | 9.51M | 10.77M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.18M | 9.64M | 9.60M | 9.51M | 10.77M |
| Cost of Revenue | 6.30M | 6.69M | 6.85M | 6.99M | 8.05M |
| Gross Profit | 2.89M | 2.95M | 2.75M | 2.52M | 2.72M |
| SG&A Expenses | 3.55M | 3.68M | 3.69M | 3.80M | 3.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.84M | 10.37M | 10.54M | 10.80M | 11.96M |
| Operating Income | -658.50K | -726.40K | -941.50K | -1.29M | -1.19M |
| Income Before Tax | -113.20K | -194.40K | -487.90K | -755.40K | -788.40K |
| Income Tax Expenses | -29.20K | -5.40K | 10.30K | 22.10K | 52.40K |
| Earnings from Continuing Operations | -0.08 | -0.19 | -0.50 | -0.78 | -0.84 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -84.30K | -189.20K | -498.40K | -777.60K | -840.80K |
| EBIT | -658.50K | -726.40K | -941.50K | -1.29M | -1.19M |
| EBITDA | -608.60K | -687.70K | -916.10K | -1.26M | -1.16M |
| EPS Basic | 0.00 | -0.01 | -0.02 | -0.03 | -0.04 |
| Normalized Basic EPS | 0.00 | -0.01 | -0.01 | -0.02 | -0.02 |
| EPS Diluted | 0.00 | -0.01 | -0.02 | -0.03 | -0.04 |
| Normalized Diluted EPS | 0.00 | -0.01 | -0.01 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 91.79M | 91.83M | 91.85M | 91.86M | 91.88M |
| Average Diluted Shares Outstanding | 91.81M | 91.84M | 91.86M | 91.89M | 91.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -2,040.21% | -909.04% | -345.55% | -221.48% | -204.83% |